Article
EGFR pathway polymorphisms and bladder cancer susceptibility and prognosis.
Carcinogenesis - 1 Jul 2009
Mason Rebecca A, Morlock Elaine V, Karagas Margaret R, Kelsey Karl T, Marsit Carmen J, Schned Alan R, Andrew Angeline S
Abstract excerpt
The epidermal growth factor receptor (EGFR) pathway has recently been appreciated as a central mediator of tumorigenesis and an important drug target; however, the influence of genetic variation in this pathway on bladder cancer is not understood. Pathway activation leads to cell proliferation, angiogenesis and is antiapoptotic. We sought to test the hypothesis that bladder cancer susceptibility and survival are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
